StockData
MoonLake Immunotherapeutics logo

MoonLake Immunotherapeutics (MLTX) dividend history

MLTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30
$11.25−0.48 (-4.09%)

Close on Nov 17, 2026Market cap $957.45MP/E –Yield –

Dividends

MoonLake Immunotherapeutics has not reported a dividend

No dividend per share appears in MoonLake Immunotherapeutics's annual filings since fiscal 2020.

See a number that looks wrong?